In contrast with our findings in LUAD tumors, recent studies have identified that, regardless of tumor type, rs78378222[C] is more frequent in tumors with no somatic-coding pathogenic TP53 variants, i.e. WT TP53 tumors (Voropaeva et al., 2020; Zhang et al., 2021). This evidence concerns the gene TP53 and neoplasm.